The concern of the Commission in this respect is that systems of prior authorisation should not suffer from the lack of legal certainty and transparency about which treatments are subject to and fit the criteria of prior authorisation.
Sellega seoses peab komisjon vajalikuks, et eellubade süsteemid oleksid õiguskindlad ning piisavalt läbipaistvad, et oleks arusaadav, millise ravi puhul eellube nõutakse ja eellubade kriteeriume kohaldatakse.